Lumen Bioscience
Lumen Bioscience engineers the edible algae spirulina to produce therapeutic proteins for orally delivered biologic drugs, as well as ingredients for human and animal nutrition. Its platform is intended to make biologic medicines faster and less costly to develop and more accessible to patients.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2017
- Type
- Corporation Seattle business license
- Employees
- 104
- Registered name
- Lumen Bioscience Inc Seattle business license
- Stage
- Series C
- Founders
- Brian Finrow, Jim Roberts
Is this your organization? Claim it
Seattle Biotech Lumen Bioscience Raises $30M Series C Extension, Adds Microsoft Vet Jeff Raikes to Board
Seattle biotech startup Lumen Bioscience raised a $30 million Series C extension led by WestRiver Group, bringing total funding to $186.8 million to advance its oral biologic drugs. The company also added Microsoft veteran Jeff Raikes to its board and announced several leadership updates.
Lumen Bioscience adds Jeff Raikes to board, promotes executives and secures $30M Series C extension led by WestRiver Group
Lumen Bioscience announced board and leadership changes—including Jeff Raikes joining as an independent director, promotions of Nhi Khuong and Kole Krieger, and appointment of David Saunders—and elected Erik Anderson as Vice Chairman. The company also closed an oversubscribed $30 million Series C extension led by WestRiver Group with participation from the Gates Foundation and several new investors to support its orally delivered biologics clinical pipeline.
Lumen Bioscience Raises $16M to Advance C. difficile Therapy; Flashpoint, Amplifier, and Tessellate BIO Report Funding and Launch Updates
Lumen Bioscience raised $16M to advance a C. difficile therapy, while Flashpoint closed a seed round, Amplifier expanded its Series A, and Tessellate BIO—founded by former Big Pharma executives—emerged from stealth.
See all 10 news stories about Lumen Bioscience.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Brian Finrow Co-Founder and Chief Executive Officer
-
Jim Roberts Co-Founder and Chief Scientific Officer